ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2019
Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol.
Christoph Schindler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.